Home › Research › Down syndrome and Alzheimer's
Role of increased cerebral myo-inositol in the dementia of Down syndrome
Shonk T, Ross BD.. Magnetic resonance in medicine, 1995-06-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
The purpose of this study was to determine cerebral myo-inositol (mI) in adults with Down syndrome (DS), and to trace the chronobiology of DS to Alzheimer disease (AD). AD has characteristic neuropathology of neurofibrillary plaques and tangles; indirect evidence links this to earlier deposition of beta-amyloid. Elevated mI, which distinguishes AD from other common dementias, is also elevated in 23 young patients who have DS without dementia. In one patient who has DS with dementia, mI is elevated and N-acetylaspartate (NAA) decreased. The similarity to AD is striking and may suggest a progressive neurochemical disorder in which elevation of mI precede loss of NAA in both AD and DS.
What this study adds
Evidence grade: Low
Elevated cerebral myo-inositol was found in 23 young people with Down syndrome without dementia and in one person with Down syndrome and dementia, resembling the pattern seen in Alzheimer's disease. The authors suggest this may reflect a progressive neurochemical disorder, but the study is small and does not test any treatment or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Shonk, T., & Ross, B. D. (1995). Role of increased cerebral myo-inositol in the dementia of Down syndrome. Magnetic resonance in medicine. https://doi.org/10.1002/mrm.1910330619
Vancouver
Shonk T, Ross BD. Role of increased cerebral myo-inositol in the dementia of Down syndrome. Magnetic resonance in medicine. 1995. doi:10.1002/mrm.1910330619. PMID: 7651126.
BibTeX
@article{shonk1995-7651126,
author = {Shonk, T. and Ross, B. D.},
title = {{Role of increased cerebral myo-inositol in the dementia of Down syndrome}},
journal = {Magnetic resonance in medicine},
year = {1995},
doi = {10.1002/mrm.1910330619},
pmid = {7651126},
url = {https://doi.org/10.1002/mrm.1910330619}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The purpose of this study was to determine cerebral myo-inositol (mI) in adults with Down syndrome (DS), and to trace the chronobiology of DS to Alzheimer disease (AD).
- AD has characteristic neuropathology of neurofibrillary plaques and tangles; indirect evidence links this to earlier deposition of beta-amyloid.
- Elevated mI, which distinguishes AD from other common dementias, is also elevated in 23 young patients who have DS without dementia.
- In one patient who has DS with dementia, mI is elevated and N-acetylaspartate (NAA) decreased.
- The similarity to AD is striking and may suggest a progressive neurochemical disorder in which elevation of mI precede loss of NAA in both AD and DS.
Why it matters
Elevated cerebral myo-inositol was found in 23 young people with Down syndrome without dementia and in one person with Down syndrome and dementia, resembling the pattern seen in Alzheimer's disease. The authors suggest this may reflect a progressive neurochemical disorder, but the study is small and does not test any treatment or prevention.
Study details
- Evidence strengthLow
How this study scored 40/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Magnetic resonance in medicine) |
| Journal's citation record | 3 / 4 | Magnetic Resonance in Medicine: journal h-index 324 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1995 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 87 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.6 citations a year over 33 year(s) since 1995 |
| Impact for its field and year | 3 / 6 | Cited 4.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 6 other studies in this library |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Brian Dale Ross: h-index 92 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | California Institute of Technology: institution h-index 1,912 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 7651126) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 40 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
6 studies in the alzhub library list this one in their references.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.